Home
OrbiMed Israel BioFund GP Limited Partnership reported a 4.8% stake in Chemomab Therapeutics CMMB · 969,807 sh · amendment
Trade details
- Type
- 5% stake report
- Report
- 13D · amendment
- Stake
- 4.8%
- Last report
- No earlier report
- Shares held
- 969,807 sh
- Class
- Ordinary Shares, no par value. American Depository Shares, each of which represents twenty Ordinary Shares, no par value
- Event date
- 25/06/18
- Filed
- 25/06/23
4.8% stake · below 5%
Chemomab Therapeutics trades, last 26 weeks
What else happened in Chemomab Therapeutics around then
Filed or reported within 30 days of the trade day · 25/05/19~25/07/18OrbiMed Israel BioFund GP Limited Partnership's other 5% stake reports
- OrbiMed Israel BioFund GP Limited Partnership
5% stakeTessera Defense & Homeland Security
5% stakeTessera Defense & Homeland Security
HLSQ
1% stake
276,150 sh
1% stake
Filed 25/06/23